DCGI allows PNB Vesper to conduct trials of PNB001 to treat COVID-19
24 Jun 2021 //
EXPRESS PHARMA
PNB Vesper gets DCGI nod to begin phase III trials for PNB 001/GPP-Balacovin
23 Jun 2021 //
PHARMABIZ
24 Jun 2021 //
EXPRESS PHARMA
23 Jun 2021 //
PHARMABIZ